• A man lounges on an oversized beanbag seat in an outdoor park setting.
    Study explores how ‘me time’ affects social interaction
    12/13/22

    How you feel about social interaction on days when you spend more time alone depends on why you wanted to be alone, a UB study finds.

  • Robert Straubinger in the lab.
    Labs find key metabolic regulators of drug resistance in pancreatic cancer
    12/13/22

    The team found several therapeutic vulnerabilities of drug resistance that could be targeted to improve outcomes.

  • Allison Brashear outside the Jacobs School.
    Brashear is elected to AAMC Council of Deans board
    12/8/22

    The council provides a national forum where medical school deans address critical issues facing academic medicine.

  • Nicolas Cuccinello.
    UB PhD student receives DOE research award
    12/8/22

    Nicholas Cucciniello will use the award to do thesis-related work at Los Alamos National Laboratory.

  • Dr. Waheed Adedeji.
    Scientist receives NIH Emerging Global Leader Award
    12/7/22

    UB CIGBS scholar Waheed Adedeji will investigate the influence of antidepressants on HIV medication among patients in Nigeria.

  • Bottle of human immunoglobulin.
    New tool developed for Kawasaki disease
    12/6/22

    The UB-developed scoring system is twice as accurate at predicting antibody resistance among U.S. children with the rare disease.

  • Steven Fliesler.
    Fliesler recognized for retina research
    12/5/22

    The SUNY Distinguished Professor has been named the 2022 recipient of the Retina Research Foundation’s Paul Kayser International Award in Retina Research.

  • activating neurons.
    An alternative method to map neuron activity
    12/2/22

    A  paper published recently by UB mathematicians suggests that “hypergraphs” 
    better explain how neuronal networks communicate.

  • Detail of a doctor's scale with a person moving the slider weights.
    Local teens with obesity see dramatic weight loss in trial
    12/2/22

    The results of a UB clinical trial on the drug semaglutide turned out to be better than anything the participants — or researchers — expected.

  • Crushing out a cigarette in an ashtray.
    Study examines pre-quit time of smoking cessation drug
    12/1/22

    A UB-led study found that extending the pre-quit duration of a leading smoking cessation medication doesn’t help smokers quit.

Next> <Previous